Plasma Therapy Market in Indonesia - Industry Outlook and Forecast 2020-2026

April 2020 | 101 pages | ID: P88ADB7BA7A9EN
Market Monitor Global

Abstracts

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

This report contains market size and forecasts of Plasma Therapy in Indonesia, including the following market information:
Indonesia Plasma Therapy Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in Indonesia Plasma Therapy Market 2019 (%)
The global Plasma Therapy market was valued at 225 million in 2019 and is projected to reach US$ 324.3 million by 2026, at a CAGR of 9.6% during the forecast period. While the Plasma Therapy market size in Indonesia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Plasma Therapy businesses, with lots of challenges and uncertainty faced by many players of Plasma Therapy in Indonesia.
This report also analyses and evaluates the COVID-19 impact on Plasma Therapy market size in 2020 and the next few years in Indonesia

Total Market by Segment:

Indonesia Plasma Therapy Market, By Type, 2015-2020, 2021-2026 ($ millions)
Indonesia Plasma Therapy Market Segment Percentages, By Type, 2019 (%)

• Pure PRP
• Leucocyte-rich PRP
• Leukocyte-rich Fibrin (L-PRF)
• In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.

Indonesia Plasma Therapy Market, By Application, 2015-2020, 2021-2026 ($ millions)
Indonesia Plasma Therapy Market Segment Percentages, By Application, 2019 (%)

• Orthopedic
• Darmatology
• Cardiac Muscle Injury
• Dental
• Nerve Injury
• Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Plasma Therapy Market Competitors Revenues in Indonesia, by Players 2015-2020 (Estimated), ($ millions)
Total Plasma Therapy Market Competitors Revenues Share in Indonesia, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:

• Terumo
• Arthrex
• Zimmer Biomet
• DePuy Synthes
• EmCyte
• Regen Lab
• ISTO Biologics
• Cesca Therapeutics
• Weigao
• REV-MED

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Plasma Therapy Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 COVID-19 Impact: Indonesia Plasma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 INDONESIA PLASMA THERAPY OVERALL MARKET SIZE

2.1 Indonesia Plasma Therapy Market Size: 2020 VS 2026
2.2 Indonesia Plasma Therapy Revenue, Prospects & Forecasts: 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Plasma Therapy Players in Indonesia (including Foreign and Local Companies)
3.2 Top Indonesia Plasma Therapy Companies Ranked by Revenue
3.3 Indonesia Plasma Therapy Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Plasma Therapy Companies in Indonesia, by Revenue in 2019
3.5 Indonesia Manufacturers Plasma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma Therapy Players in Indonesia
  3.6.1 List of Indonesia Tier 1 Plasma Therapy Companies
  3.6.2 List of Indonesia Tier 2 and Tier 3 Plasma Therapy Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Indonesia Plasma Therapy Market Size Markets, 2020 & 2026
  4.1.2 Pure PRP
  4.1.3 Leucocyte-rich PRP
  4.1.4 Leukocyte-rich Fibrin (L-PRF)
4.2 By Type - Indonesia Plasma Therapy Revenue & Forecasts
  4.2.1 By Type - Indonesia Plasma Therapy Revenue, 2015-2020
  4.2.2 By Type - Indonesia Plasma Therapy Revenue, 2021-2026
  4.2.3 By Type - Indonesia Plasma Therapy Revenue Market Share, 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Indonesia Plasma Therapy Market Size, 2020 & 2026
  5.1.2 Orthopedic
  5.1.3 Darmatology
  5.1.4 Cardiac Muscle Injury
  5.1.5 Dental
  5.1.6 Nerve Injury
5.2 By Application - Indonesia Plasma Therapy Revenue & Forecasts
  5.2.1 By Application - Indonesia Plasma Therapy Revenue, 2015-2020
  5.2.2 By Application - Indonesia Plasma Therapy Revenue, 2021-2026
  5.2.3 By Application - Indonesia Plasma Therapy Revenue Market Share, 2015-2026

6 PLAYERS PROFILES

6.1 Terumo
  6.1.1 Terumo Corporate Summary
  6.1.2 Terumo Business Overview
  6.1.3 Terumo Plasma Therapy Major Product Offerings
  6.1.4 Terumo Revenue in Indonesia (2015-2020)
  6.1.5 Terumo Key News
6.2 Arthrex
  6.2.1 Arthrex Corporate Summary
  6.2.2 Arthrex Business Overview
  6.2.3 Arthrex Plasma Therapy Major Product Offerings
  6.2.4 Arthrex Revenue in Indonesia (2015-2020)
  6.2.5 Arthrex Key News
6.3 Zimmer Biomet
  6.3.1 Zimmer Biomet Corporate Summary
  6.3.2 Zimmer Biomet Business Overview
  6.3.3 Zimmer Biomet Plasma Therapy Major Product Offerings
  6.3.4 Zimmer Biomet Revenue in Indonesia (2015-2020)
  6.3.5 Zimmer Biomet Key News
6.4 DePuy Synthes
  6.4.1 DePuy Synthes Corporate Summary
  6.4.2 DePuy Synthes Business Overview
  6.4.3 DePuy Synthes Plasma Therapy Major Product Offerings
  6.4.4 DePuy Synthes Revenue in Indonesia (2015-2020)
  6.4.5 DePuy Synthes Key News
6.5 EmCyte
  6.5.1 EmCyte Corporate Summary
  6.5.2 EmCyte Business Overview
  6.5.3 EmCyte Plasma Therapy Major Product Offerings
  6.5.4 EmCyte Revenue in Indonesia (2015-2020)
  6.5.5 EmCyte Key News
6.6 Regen Lab
  6.6.1 Regen Lab Corporate Summary
  6.6.2 Regen Lab Business Overview
  6.6.3 Regen Lab Plasma Therapy Major Product Offerings
  6.6.4 Regen Lab Revenue in Indonesia (2015-2020)
  6.6.5 Regen Lab Key News
6.7 ISTO Biologics
  6.6.1 ISTO Biologics Corporate Summary
  6.6.2 ISTO Biologics Business Overview
  6.6.3 ISTO Biologics Plasma Therapy Major Product Offerings
  6.4.4 ISTO Biologics Revenue in Indonesia (2015-2020)
  6.7.5 ISTO Biologics Key News
6.8 Cesca Therapeutics
  6.8.1 Cesca Therapeutics Corporate Summary
  6.8.2 Cesca Therapeutics Business Overview
  6.8.3 Cesca Therapeutics Plasma Therapy Major Product Offerings
  6.8.4 Cesca Therapeutics Revenue in Indonesia (2015-2020)
  6.8.5 Cesca Therapeutics Key News
6.9 Weigao
  6.9.1 Weigao Corporate Summary
  6.9.2 Weigao Business Overview
  6.9.3 Weigao Plasma Therapy Major Product Offerings
  6.9.4 Weigao Revenue in Indonesia (2015-2020)
  6.9.5 Weigao Key News
6.10 REV-MED
  6.10.1 REV-MED Corporate Summary
  6.10.2 REV-MED Business Overview
  6.10.3 REV-MED Plasma Therapy Major Product Offerings
  6.10.4 REV-MED Revenue in Indonesia (2015-2020)
  6.10.5 REV-MED Key News
6.11 Nuo Therapeutics
  6.11.1 Nuo Therapeutics Corporate Summary
  6.11.2 Nuo Therapeutics Plasma Therapy Business Overview
  6.11.3 Nuo Therapeutics Plasma Therapy Major Product Offerings
  6.11.4 Nuo Therapeutics Revenue in Indonesia (2015-2020)
  6.11.5 Nuo Therapeutics Key News

7 KEY MARKET TRENDS & INFLUENCES 2021-2026

7.1 PESTLE Analysis for Indonesia Plasma Therapy Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Plasma Therapy in Indonesia
Table 2. Top Players in Indonesia, Ranking by Revenue (2019)
Table 3. Indonesia Plasma Therapy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Indonesia Plasma Therapy Revenue Share by Companies, 2015-2020
Table 5. Indonesia Plasma Therapy Sales by Companies, (K Units), 2015-2020
Table 6. Indonesia Plasma Therapy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Plasma Therapy Price (2015-2020) (US$/Unit)
Table 8. Indonesia Manufacturers Plasma Therapy Product Type
Table 9. List of Indonesia Tier 1 Plasma Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Indonesia Tier 2 and Tier 3 Plasma Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Plasma Therapy Revenue in Indonesia (US$, Mn), 2015-2020
Table 12. By Type - Plasma Therapy Revenue in Indonesia (US$, Mn), 2021-2026
Table 13. By Type - Plasma Therapy Sales in Indonesia (K Units), 2015-2020
Table 14. By Type - Plasma Therapy Sales in Indonesia (K Units), 2021-2026
Table 15. By Application - Plasma Therapy Revenue in Indonesia, (US$, Mn), 2015-2020
Table 16. By Application - Plasma Therapy Revenue in Indonesia, (US$, Mn), 2021-2026
Table 17. By Application - Plasma Therapy Sales in Indonesia, (K Units), 2015-2020
Table 18. By Application - Plasma Therapy Sales in Indonesia, (K Units), 2021-2026
Table 19. Terumo Corporate Summary
Table 20. Terumo Plasma Therapy Product Offerings
Table 21. Terumo Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 22. Arthrex Corporate Summary
Table 23. Arthrex Plasma Therapy Product Offerings
Table 24. Arthrex Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 25. Zimmer Biomet Corporate Summary
Table 26. Zimmer Biomet Plasma Therapy Product Offerings
Table 27. Zimmer Biomet Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 28. DePuy Synthes Corporate Summary
Table 29. DePuy Synthes Plasma Therapy Product Offerings
Table 30. DePuy Synthes Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 31. EmCyte Corporate Summary
Table 32. EmCyte Plasma Therapy Product Offerings
Table 33. EmCyte Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 34. Regen Lab Corporate Summary
Table 35. Regen Lab Plasma Therapy Product Offerings
Table 36. Regen Lab Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 37. ISTO Biologics Corporate Summary
Table 38. ISTO Biologics Plasma Therapy Product Offerings
Table 39. ISTO Biologics Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 40. Cesca Therapeutics Corporate Summary
Table 41. Cesca Therapeutics Plasma Therapy Product Offerings
Table 42. Cesca Therapeutics Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 43. Weigao Corporate Summary
Table 44. Weigao Plasma Therapy Product Offerings
Table 45. Weigao Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 46. REV-MED Corporate Summary
Table 47. REV-MED Plasma Therapy Product Offerings
Table 48. REV-MED Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 49. Nuo Therapeutics Corporate Summary
Table 50. Nuo Therapeutics Plasma Therapy Product Offerings
Table 51. Nuo Therapeutics Plasma Therapy Revenue (US$, Mn), (2015-2020)

List Of Figures

LIST OF FIGURES

Figure 1. Plasma Therapy Segment by Type
Figure 2. Plasma Therapy Segment by Application
Figure 3. Indonesia Plasma Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Plasma Therapy Market Size in Indonesia, (US$, Mn): 2020 VS 2026
Figure 6. Indonesia Plasma Therapy Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma Therapy Revenue in 2019
Figure 8. By Type - Indonesia Plasma Therapy Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - Indonesia Plasma Therapy Market Share, 2015-2026
Figure 10. By Application - Plasma Therapy Revenue in Indonesia (US$, Mn), 2020 & 2026
Figure 11. By Application - Indonesia Plasma Therapy Market Share, 2015-2026
Figure 12. PEST Analysis for Indonesia Plasma Therapy Market in 2020
Figure 13. Plasma Therapy Market Opportunities & Trends in Indonesia
Figure 14. Plasma Therapy Market Drivers in Indonesia